Can Philadelphia's biotechnology industry absorb the jobs lost from pharmaceutical companies? Kerry Grens investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
An eastern promise of regeneration
The pharmaceutical industry has had big job losses of late.
Related external links
Greater Philadelphia Senior Executive Group
Rights and permissions
About this article
Cite this article
Grens, K. Eyeing the underdog. Nature 461, 300–301 (2009). https://doi.org/10.1038/nj7261-300a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7261-300a
